6t33: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='6t33' size='340' side='right'caption='[[6t33]]' scene=''> | <StructureSection load='6t33' size='340' side='right'caption='[[6t33]]' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'> | <table><tr><td colspan='2'>Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6T33 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6T33 FirstGlance]. <br> | ||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6t33 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6t33 OCA], [https://pdbe.org/6t33 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6t33 RCSB], [https://www.ebi.ac.uk/pdbsum/6t33 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6t33 ProSAT]</span></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6t33 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6t33 OCA], [https://pdbe.org/6t33 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6t33 RCSB], [https://www.ebi.ac.uk/pdbsum/6t33 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6t33 ProSAT]</span></td></tr> | |||
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Latest revision as of 06:08, 19 June 2024
The unusual structure of Ruminococcin C1 antimicrobial peptide confers activity against clinical pathogens
| ||||||||||||